Posted On: 01/21/2016 9:34:20 AM
Post# of 30034
That was a really excited guy. I liked how he schooled Gerald into selling him the diagnostics, saying, "Do you really think that a spin-off would be a good idea", and basically changing Geralds mind about the direction he was planning on going.
So, the way I read this is, we are now at the mercy of another company as to whether or not they can get funding. I like how he was thinking they would be able to up-list to another exchange. Its almost like Gerald past him the hot potato (which is the failure to be able to attract any worthwhile non toxic funding on the tests and zero BP interest) and now they have it and we have nothing but shares of another penny stock that is going to have to figure out how to get all these tests to market and hopefully find someone that wants them.
Explain how three years later, with all the Lympro "change math" promises, we are in a better position in terms of cash and/or cash flow? The CEO mentioned that Gerald got himself into trouble (by basically being a knucklehead without actually saying it) with toxic funding. If he knows it, then the rest of the industry knows it.
Again, who would invest in a company with an inept CEO? Who would invest in the company, just looking at the share price history, reading the chairman's blogs, and all of the fluff?
So, my takeaway is this- that was a waste of time. we now know the reason that the other company relinquished control of Lympro for basically pennies and we still have no hard cash. AND this was Geralds BIG surprise for new around JP Morgan. This just get crazier every day. So, how many of you are going to vote that he stays the CEO the next time asked?
So, the way I read this is, we are now at the mercy of another company as to whether or not they can get funding. I like how he was thinking they would be able to up-list to another exchange. Its almost like Gerald past him the hot potato (which is the failure to be able to attract any worthwhile non toxic funding on the tests and zero BP interest) and now they have it and we have nothing but shares of another penny stock that is going to have to figure out how to get all these tests to market and hopefully find someone that wants them.
Explain how three years later, with all the Lympro "change math" promises, we are in a better position in terms of cash and/or cash flow? The CEO mentioned that Gerald got himself into trouble (by basically being a knucklehead without actually saying it) with toxic funding. If he knows it, then the rest of the industry knows it.
Again, who would invest in a company with an inept CEO? Who would invest in the company, just looking at the share price history, reading the chairman's blogs, and all of the fluff?
So, my takeaway is this- that was a waste of time. we now know the reason that the other company relinquished control of Lympro for basically pennies and we still have no hard cash. AND this was Geralds BIG surprise for new around JP Morgan. This just get crazier every day. So, how many of you are going to vote that he stays the CEO the next time asked?
(0)
(0)Scroll down for more posts ▼
